Qube Research & Technologies (QRT)’s Design Therapeutics DSGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DSGN Stock Details DSGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.32M	Buy	437,079 +402,896	+1,179%	+$5.02M	0.01%	1521
2026 Q1	$364K	Buy	+34,183	New	+$346K	﹤0.01%	2828
2024 Q3	–	Sell	-2,986	Closed	-$10K	–	3491
2024 Q2	$10K	Buy	+2,986	New	+$11.6K	﹤0.01%	2962
2022 Q2	–	Sell	-20,396	Closed	-$329K	–	2630
2022 Q1	$329K	Sell	20,396 -2,656	-12%	-$40.7K	﹤0.01%	1736
2021 Q4	$494K	Buy	+23,052	New	+$396K	﹤0.01%	1574

Other funds holding DSGN

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Qube Research & Technologies (QRT)'s DSGN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Design Therapeutics (DSGN) stake by 1,179% in Q2 2026, buying an estimated $5.02M and bringing the position to 437,079 shares worth $6.32M. The position accounts for 0.01% of the portfolio, ranked #1521.

Qube Research & Technologies (QRT) first reported a position in DSGN in Q4 2021 and has held it in 5 quarters since. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

Qube Research & Technologies (QRT) held 437,079 shares of Design Therapeutics worth $6.32M as of Q2 2026.
Qube Research & Technologies (QRT) bought 402,896 Design Therapeutics shares in Q2 2026, an estimated $5.02M.
Design Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1521 holding.
Qube Research & Technologies (QRT) first reported a position in Design Therapeutics in Q4 2021 and has held it in 5 quarters since.
136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.